OR WAIT null SECS
May 25, 2016
May 12, 2016
The agency and national authority representatives talk about regulators’ role in keeping drug prices affordable.
The agency summarizes the results of its 10-year-long initiative to support small- and medium-sized enterprises.
May 11, 2016
Members of ABPI, GSK, AstraZeneca, and the BioIndustry Association composed a letter explaining why the UK remaining part of the EU benefits the life-sciences sector.
May 02, 2016
In a move to encourage drug development, EU regulators are offering scientific advice to companies on major efficacy, safety, and quality issues at an early stage.
The author looks at EUCAST’s role in tackling the spread of antimicrobial resistance, by creating definitions for a global consensus.
April 28, 2016
The agency holds a workshop to strengthen collaboration with healthcare providers.
April 19, 2016
PRAC said it has plans to review both canagliflozin and several direct-acting antivirals, after new study data showed potential risks associated with the drugs.
April 14, 2016
The agencies detail the results of their three-year collaboration.
April 06, 2016
The agency released a draft reflection paper on the extrapolation of data from adults to children in the development of pediatric drugs.